European biotechs migrate to Nasdaq
Interviewee/Contributor
Victoria English
Organisation
MedNous
Stock market performance
Low interest rates, vaccines carry stock values higher
Interviewee/Contributor
William Ellington
Organisation
MedNous
Christmas comes early for Europe's biotech stocks
Interviewee/Contributor
William Ellington
Organisation
MedNous
Biotech shares bounce back
Interviewee/Contributor
William Ellington
Organisation
MedNous
Biotechs fare relatively well amidst share collapse
Interviewee/Contributor
William Ellington
Organisation
MedNous
Welcome to the Euro-Nasdaq waltz
Interviewee/Contributor
William Ellington
Organisation
MedNous
European biotechs narrowly ahead
Interviewee/Contributor
William Ellington
Organisation
MedNous
Investors show caution about biotechs
Interviewee/Contributor
William Ellington
Organisation
MedNous
Partial recovery of biotechs
Interviewee/Contributor
William Ellington
Organisation
MedNous
2018 Fourth quarter stock market review
Interviewee/Contributor
William Ellington
Organisation
MedNous